Module 3: Oral Antiviral Administration
Patient Flow for Antiviral Oral Therapies
(When product not available onsite)
Assessment and Prescribing
Confirm diagnosis of COVID-19 infection
Discuss treatment with patient
- Ensure patient meets treatment requirements and understands risks
Prescribe therapy for patient & provide the medication fact sheet (for product under EUA)
Visit Discharge
Prescription provided to the patient
- Ensure patient understands medication therapy being provided
- Ensure medication therapy being dispensed complies with federal/state dispensing laws
Discuss treatment with patient
- Ensure patient meets treatment requirements and understands risks
Prescribe therapy for patient & provide the medication fact sheet (for product under EUA)
- Document required patient assessment in medical record
- Provide patient education on medication therapy being prescribed
Determine locations medication is available in local area.
Post-visit
Pharmacist receives or prescribes patient prescription
- Pharmacy should prioritize the prescription fill and ensure timely turnaround to support same day start for therapy
- Pharmacist verifies prescription is appropriate for patient. Any concerns are clarified with prescribing provider
Pharmacy staff dispenses product to the patient
- Patient is counseled on medication therapy and reminded to start immediately
Patient to begin prescribed therapy immediately and continue x 5 days
Patient to report any adverse effect to FDA MedWatch
- Patients that present for hospital visit may continue their prescribed antiviral during hospitalization (at discretion of provider)
Test to Treat: About the Program
- Overall goal of Test to Treat program is to increase access to COVID-19 oral therapeutics, particularly for individuals who don't have ready access to a health care provider.
- Sites with Test to Treat services give patients the option to get tested, get assessed by a healthcare provider, and receive treatment – all in one visit.
- COVID-19 treatments delivered as part of Test to Treat Program (Paxlovid and Lagevrio) must be taken within 5 days of initial COVID-19 symptoms.
- Helps close gap between positive COVID-19 test and receiving treatment for those eligible.
- An individual's healthcare providers remain the first option for care; Test to Treat sites are one additional access point.
Treatments Locator
- The Treatments Locator displays pharmacies, clinics, and other locations with safe and effective COVID-19 medications.
- Users can find locations offering Test to Treat, telehealth, home delivery, and testing services for eligible patients.
- Locations participating in the U.S. Government Patient Assistance Program operated by Pfizer offering free Paxlovid for eligible patients are included on this website.
- For questions regarding this site, contact 1-800-232-0233 (TTY 888-720-7489).
Find Test to Treat locations on the Treatments Locator